Oligoprogression After Immunotherapy and Targeted Therapy in Metastatic Melanoma

Oncology (Williston Park). 2021 Sep 16;35(9):562-566. doi: 10.46883/ONC.2021.3509.0562.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Female
  • Humans
  • Immunotherapy
  • Melanoma / genetics
  • Melanoma / pathology
  • Melanoma / therapy*
  • Middle Aged
  • Molecular Targeted Therapy
  • Mutation
  • Neoplasm Metastasis
  • Proto-Oncogene Proteins B-raf / genetics
  • Skin Neoplasms / genetics
  • Skin Neoplasms / pathology
  • Skin Neoplasms / therapy*

Substances

  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf